Search Results - "Hoernschemeyer, Joerg"
-
1
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Published in Nature neuroscience (01-07-2019)“…Parkinson’s disease, the most common age-related movement disorder, is a progressive neurodegenerative disease with unclear etiology. Key neuropathological…”
Get full text
Journal Article -
2
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
Published in eLife (14-02-2017)“…Invasion of erythrocytes by merozoites is a composite process involving the interplay of several proteins. Among them, the Cysteine-Rich Protective Antigen…”
Get full text
Journal Article -
3
Potent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport
Published in EBioMedicine (01-10-2017)“…Therapeutic approaches to fight Alzheimer's disease include anti-Amyloidβ (Aβ) antibodies and secretase inhibitors. However, the blood-brain barrier (BBB)…”
Get full text
Journal Article -
4
Metabolism of the unnatural anticancer lipid safingol, l-threo-dihydrosphingosine, in cultured cells
Published in Journal of lipid research (01-09-2003)“…We studied the metabolism of radioactively labeled safingol (l-threo-dihydrosphingosine) in primary cultured neurons, B104 neuroblastoma cells, and Swiss 3T3…”
Get full text
Journal Article -
5
Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization
Published in Protein expression and purification (01-03-2004)“…The GM2-activator protein (GM2AP) belongs to a group of five small, nonenzymatic proteins that are essential cofactors for the degradation of…”
Get full text
Journal Article -
6
Expression of recombinant human GM2-activator protein in insect cells: purification and characterization by mass spectrometry
Published in Protein expression and purification (01-02-2003)“…The GM2-activator protein (GM2AP) is a small non-enzymatic cofactor assisting the enzyme β-hexosaminidase A in the lysosomal degradation of ganglioside GM2…”
Get full text
Journal Article -
7
Development of stable liquid formulations for oligonucleotides
Published in European journal of pharmaceutics and biopharmaceutics (01-08-2018)“…[Display omitted] Oligonucleotide-based therapeutics have been implemented as a new therapeutic modality in biotech industry, which offers the opportunity to…”
Get full text
Journal Article -
8
Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes
Published in The Journal of biological chemistry (28-03-2003)“…Exosomes are 60â100-nm membrane vesicles that are secreted into the extracellular milieu as a consequence of multivesicular body fusion with the plasma…”
Get full text
Journal Article -
9
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation
Published in The Journal of biological chemistry (28-03-2003)“…Exosomes are 60-100-nm membrane vesicles that are secreted into the extracellular milieu as a consequence of multivesicular body fusion with the plasma…”
Get full text
Journal Article -
10
Glycation during storage and administration of monoclonal antibody formulations
Published in European journal of pharmaceutics and biopharmaceutics (01-09-2008)“…Covalent modifications of therapeutic proteins are of interest for the biotech industry as they potentially impact the quality of the material. This study…”
Get full text
Journal Article -
11
Distinguishing the topology of macrocyclic compounds and catenanes
Published in International journal of mass spectrometry (15-08-2003)“…The paper explores different possibilities to distinguish macrocyclic oligolactam species with different molecular topologies by ESI mass spectrometry…”
Get full text
Journal Article -
12
Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation
Published in European journal of biochemistry (01-02-2004)“…The GM2-activator protein (GM2AP) is an essential cofactor for the degradation of ganglioside GM2 by lysosomal beta-hexosaminidase A. It mediates the…”
Get full text
Journal Article -
13
Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay
Published in Methods in enzymology (2003)Get more information
Journal Article -
14
Human acid sphingomyelinase: Assignment of the disulfide bond pattern
Published in European journal of biochemistry (01-03-2003)“…Human acid sphingomyelinase (haSMase, EC 3.1.4.12) catalyzes the lysosomal degradation of sphingomyelin to ceramide and phosphorylcholine. An inherited haSMase…”
Get full text
Journal Article -
15
Photoaffinity labelling of the Human GM2‐activator protein
Published in European journal of biochemistry (01-02-2004)“…The GM2‐activator protein (GM2AP) is an essential cofactor for the degradation of ganglioside GM2 by lysosomal β‐hexosaminidase A. It mediates the interaction…”
Get full text
Journal Article -
16
Human acid sphingomyelinase
Published in European journal of biochemistry (01-03-2003)“…Human acid sphingomyelinase (haSMase, EC 3.1.4.12) catalyzes the lysosomal degradation of sphingomyelin to ceramide and phosphorylcholine. An inherited haSMase…”
Get full text
Journal Article